Treatment modes in rheumatoid arthritis: factors influencing patient preference by Taylor, P, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce de Leon, D, Gruben, D, Fallon, L

Treatment mode preferences in rheumatoid arthritis: moving toward shared decision-making by Taylor, PC, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce De Leon, D, Gruben, D, Fallon, L

Treatment modes in rheumatoid arthritis: Moving toward shared decision-making by Taylor, P, Betteridge, N, Brown, T, Woolcott, J, Kivitz, A, Zerbini, C, Whalley, D, Olayinka-Amao, O, Chen, C, Dahl, P, Ponce de Leon, D, Gruben, D, Fallon, L

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making by Taylor PC, Betteridge N, Brown TM, Woolcott J, Kivitz AJ, Zerbini C, Whalley D, Olayinka-Amao O, Chen C, Dahl P, Ponce de Leon D, Gruben D, Fallon L

Get full text

Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis by Emery, P, Dudler, J, Smolen, J, Zerbini, C, Burmester, G, Fautrel, B, Van Der Laar, M, Fleischmann, R, Fakhouri, W, De Leonardis, F, Zhu, B, Kadziola, Z, De La Torre, I, Perrier, C, Taylor, P